RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.93B
AUM Growth
+$243M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$95M
2
+$77.3M
3
+$72.9M
4
PCVX icon
Vaxcyte
PCVX
+$61.2M
5
ACRV icon
Acrivon Therapeutics
ACRV
+$55.4M

Top Sells

1
+$180M
2
+$112M
3
+$74.6M
4
RLMD icon
Relmada Therapeutics
RLMD
+$74M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.5M

Sector Composition

1 Healthcare 99.36%
2 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$11.8M 0.24%
3,370,506
52
$10.1M 0.2%
1,000,000
53
$8.8M 0.18%
4,291,881
54
$7.57M 0.15%
590,218
55
$6.36M 0.13%
1,088,296
56
$6.09M 0.12%
610,283
57
$6.07M 0.12%
6,991,003
58
$5.96M 0.12%
188,130
+330
59
$5.32M 0.11%
5,914,252
60
$5.05M 0.1%
275,000
61
$4.66M 0.09%
2,589,904
62
$3M 0.06%
195,896
-176,578
63
$2.59M 0.05%
1,127,260
-730,495
64
$2.3M 0.05%
534,687
-2,941,000
65
$2.08M 0.04%
659,992
66
$1.45M 0.03%
1,607,834
-3,406,853
67
$1.15M 0.02%
143,900
-4,458,578
68
$885K 0.02%
+632,184
69
$289K 0.01%
+333,333
70
$216K ﹤0.01%
295,966
-1,786,406
71
– –
-6,175,038
72
– –
-1,000,000
73
– –
-2,059,372
74
– –
-26,672
75
– –
-224,255
1 2
3
4